Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.31 USD
−6.48 M USD
0.00 USD
833.81 K
About Scinai Immunotherapeutics Ltd.
Sector
CEO
Amir Reichman
Headquarters
Jerusalem
Website
Founded
2003
FIGI
BBG007TGL1R2
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.